One of the few drug developers based in Worcester is leaving Wormtown for Waltham. Also, Novo Nordisk and Eli Lilly have ...

The asset also has potential applications in metabolic diseases and oncology, according to the biotech. Eli Lilly inks duo of deals, teaming with AdvanCell, OliX to push deeper into radiopharma ...

In October, Eli Lilly announced a $4.5 billion investment to create the Lilly Medicine Foundry, a new center for advanced manufacturing and drug development. Price Action: LLY stock is down 0.42% ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE ... according to CNBC. Biotech companies are further pushed into making these deals due to the drying up of ...

Lilly inked a deal in 2021 with exactly that protein-destroying goal in mind, promising potentially more than $1.6 billion to Lycia Therapeutics to find molecular glues for difficult targets in ...

Want to stay on top of the science and politics driving biotech today ... a shortage of the primary alternative for children. Eli Lilly CEO Dave Ricks made $114 million last year, according ...

Drugmaker Eli Lilly plans to build four new manufacturing plants in the U.S., a $27 billion investment that the company expects will create 3,000 high-skilled jobs and employ 10,000 construction ...

Eli Lilly (NYSE ... of two positive press releases. In one, Lilly announced plans to acquire the farnesoid X receptor (FXR) program of clinical-stage biotech Organovo (NASDAQ: ONVO), including ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Oh hi. Today, we talk about Eli Lilly’s plan to invest $27 billion ...